0001209191-21-065539.txt : 20211118
0001209191-21-065539.hdr.sgml : 20211118
20211118171128
ACCESSION NUMBER: 0001209191-21-065539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211118
FILED AS OF DATE: 20211118
DATE AS OF CHANGE: 20211118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CZEREPAK ELIZABETH
CENTRAL INDEX KEY: 0001263500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36150
FILM NUMBER: 211425319
MAIL ADDRESS:
STREET 1: 201 ROUTE 17 NORTH
CITY: RUTHERFORD
STATE: NJ
ZIP: 07070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc.
CENTRAL INDEX KEY: 0000850261
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330344842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4955 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-203-4100
MAIL ADDRESS:
STREET 1: 4955 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-18
0
0000850261
Sorrento Therapeutics, Inc.
SRNE
0001263500
CZEREPAK ELIZABETH
C/O SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
6.01
2021-11-18
4
A
0
100000
0.00
A
2031-11-18
Common Stock
100000
100000
D
1/12th of the original number of shares subject to the option shall vest on December 18, 2021, and 1/12th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
/s/ Henry Ji, Ph.D., as attorney-in-fact
2021-11-18